Obstructive lung disease: Difference between revisions
Usama Talib (talk | contribs) |
|||
Line 7: | Line 7: | ||
==Overview== | ==Overview== | ||
Obstructive lung disease is a group of diseases that present with | Obstructive lung disease is a group of diseases characterized by various deformities that result in collapse of airways. Obstructive lung diseases present with an obstructive pattern that is an increase in total lung capacity (TLC), increase in respiratory volume (RV), a decrease in forced vital capacity (FVC), a decreased forced expiratory volume (FEV1), and a decreased FEV1/FVC, on pulmonary function tests. Patients suffering with obstructive lung disease usually present with shortness of breath due to damage to the airways within the lungs. This results in an in ability to exhale air completely and an abnormally high amount of air may still present in the lungs after the end of full expiration. These diseases include [[asthma]], [[COPD]], [[bronchiolitis]], [[bronchiectasis]], [[heart failure]], [[tuberculosis]], [[cystic fibrosis]], and [[lymphangioleiomyomatosis]]. | ||
==Classification== | ==Classification== |
Revision as of 18:11, 10 March 2018
Obstructive lung disease Microchapters |
Differentiating Obstructive Lung Disease from other Diseases |
---|
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Feham Tariq, MD [2], Dildar Hussain, MBBS [3], Usama Talib, BSc, MD [4]
Overview
Obstructive lung disease is a group of diseases characterized by various deformities that result in collapse of airways. Obstructive lung diseases present with an obstructive pattern that is an increase in total lung capacity (TLC), increase in respiratory volume (RV), a decrease in forced vital capacity (FVC), a decreased forced expiratory volume (FEV1), and a decreased FEV1/FVC, on pulmonary function tests. Patients suffering with obstructive lung disease usually present with shortness of breath due to damage to the airways within the lungs. This results in an in ability to exhale air completely and an abnormally high amount of air may still present in the lungs after the end of full expiration. These diseases include asthma, COPD, bronchiolitis, bronchiectasis, heart failure, tuberculosis, cystic fibrosis, and lymphangioleiomyomatosis.
Classification
Various diseases that present with an obstructive pattern on pulmonary function tests include:
- Asthma
- COPD
- Bronchiolitis
- Bronchiectasis
- Heart failure
- Tuberculosis
- Lymphangioleiomyomatosis
- Cystic fibrosis
Spirometry Findings in Various Lung Conditions
Spirometry can help distinguish obstructive lung disease from restrictive lung disease. On spirometry the findings include:[1][2]
|
Approach to Lung Disorders
Spirometry | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Low FEV1/FVC ratio | Normal to high FEV1/FVC ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Obstructive Lung Disease | Restrictive Lung Disease | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bronchodilator therapy | DLCO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Increased FEV1 | No change in FEV1 | Normal DLCO | Decreased DLCO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Asthma | COPD | Chest wall disorders | Interstitial Lung Disease | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Differentiating Obstructive Lung Disease from other Diseases
Various diseases presenting with obstructive pattern on pulmonary function tests can be differentiated from each other as follows:
Diseases | Clinical manifestations | Diagnosis | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Signs | Lab findings | PFT | Imaging | Gold standard | Other features | ||||||||||||||
Cough | Dyspnea | Hemoptysis | Fever | Weight loss | Cyanosis | Clubbing | JVD | Peripheral edema | Auscultation | ABGs | FEV1/FVC | TLC | DLCO | |||||||
CXR | CT scan | Other tests | ||||||||||||||||||
Asthma | + | + | ± | ± | − | − | − | − | − |
|
|
|
FEV1:FVC =<0.7 |
|
|
|
|
|
|
Associated with:
|
Chronic bronchitis | + | + | ± | + | − | − | − | − | − |
|
|
|
|
|
|
|
|
Microbiological testing is done in cases of:
|
|
|
Bronchiolitis | + | + | − | + | − | − | − | − | – |
|
|
|
|
|
|
|
|
|
Can be associated with:
| |
Emphysema | + | + | – | + | + | + | + | – | – |
|
|
|
|
|
– |
|
|
|
|
|
Bronchiectasis | + | + | + | + | – | + | + | – | – |
|
|
|
|
|
|
|
|
| ||
Heart failure | + | + | – | – | – | + | – | + | + |
|
|
|
|
|
|
|
||||
Tuberculosis | + | + | + | + | + | – | – | – | – |
|
|
|
|
|||||||
Lymphangioleiomyomatosis | + | + | +(<5%) | - | - | - | +(rare) | - | + |
|
|
|
|
|
|
|
|
|
|
|
Status Asthmaticus | + | + | - | ± | - | - | - | + | - |
|
|
|
|
|
|
|
- |
|
|
|
Cystic fibrosis | + | + | + | + | - | + | + | - | - |
|
|
|
|
|
|
References
- ↑ Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson DC, MacIntyre N, McKay R, Miller MR, Navajas D, Pedersen OF, Wanger J (November 2005). "Interpretative strategies for lung function tests". Eur. Respir. J. 26 (5): 948–68. doi:10.1183/09031936.05.00035205. PMID 16264058.
- ↑ Mehrparvar AH, Sakhvidi MJ, Mostaghaci M, Davari MH, Hashemi SH, Zare Z (2014). "Spirometry values for detecting a restrictive pattern in occupational health settings". Tanaffos. 13 (2): 27–34. PMC 4260070. PMID 25506373.
- ↑ Gaeta M, Minutoli F, Girbino G, Murabito A, Benedetto C, Contiguglia R, Ruggeri P, Privitera S (2013). "Expiratory CT scan in patients with normal inspiratory CT scan: a finding of obliterative bronchiolitis and other causes of bronchiolar obstruction". Multidiscip Respir Med. 8 (1): 44. doi:10.1186/2049-6958-8-44. PMC 3710098. PMID 23835554.
- ↑ Park JE, Kim Y, Lee SW, Shim SS, Lee JK, Lee JH (2016). "The usefulness of low-dose CT scan in elderly patients with suspected acute lower respiratory infection in the emergency room". Br J Radiol. 89 (1060): 20150654. doi:10.1259/bjr.20150654. PMC 4846199. PMID 26861744.
- ↑ Espiritu JD, Ruppel G, Shrestha Y, Kleinhenz ME (June 2003). "The diffusing capacity in adult cystic fibrosis". Respir Med. 97 (6): 606–11. PMID 12814143.